Analystreport

Tenax Therapeutics, Inc. (NASDAQ: TENX) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $30.00 price target on the stock.

Tenax Therapeutics, Inc.  (TENX) 
Last tenax therapeutics, inc. earnings: 11/14 04:31 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.tenaxthera.com